Essential tremor-plus: a controversial new concept
- 1 March 2020
- journal article
- review article
- Published by Elsevier in The Lancet Neurology
- Vol. 19 (3) , 266-270
Abstract
No abstract availableKeywords
Funding Information
- Teva Pharmaceutical Industries
- Indian Council of Medical Research
- F. Hoffmann-La Roche
- Allergan
- International Parkinson and Movement Disorder Society
- National Medical Research Council
- CHDI Foundation
- Department of Science and Technology, Ministry of Science and Technology, India
- Dystonia Coalition
- National Institutes of Health
- Neurocrine Biosciences
- National Institute of Neurological Disorders and Stroke (01 NS073872, 01 NS085136, 01 NS088257, 01 NS094607)
- University of Cambridge
- Yale University
- Parkinson's Foundation
- ACADIA Pharmaceuticals
This publication has 63 references indexed in Scilit:
- The Pathophysiology of Essential Tremor and Parkinson’s TremorCurrent Neurology and Neuroscience Reports, 2013
- Increased number of Purkinje cell dendritic swellings in essential tremorEuropean Journal of Neurology, 2011
- Tandem gait performance in essential tremor: Clinical correlates and association with midline tremorsMovement Disorders, 2010
- Essential tremor is associated with dementiaNeurology, 2009
- Intention tremor in essential tremor: Prevalence and association with disease durationMovement Disorders, 2009
- Essential Tremor: From a Monosymptomatic Disorder to a More Complex EntityNeuroepidemiology, 2008
- Essential tremor: predictors of disease progression in a clinical cohortJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Essential tremor: predictors of disease progression in a clinical cohortJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Focal dystonia as a presenting sign of spinocerebellar ataxia 17Movement Disorders, 2003
- Essential tremor is a monosymptomatic disorderMovement Disorders, 2002